Edit |   |
---|---|
Antigenic Specificity | Ensituximab (biosimilar) |
Clone | monoclonal |
Host Species | Recombinant |
Reactive Species | n/a |
Isotype | IgG1 kappa |
Format | purified |
Size | 5 mg, 1 mg |
Concentration | 1mg/ml |
Applications | ELISA, FC, Functional Studies, ICC, IF, IP, NeA |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Ensituximab (NPC-1C) is a chimeric monoclonal antibody under development for as a candidate for treatment of cancers. The target of the antibody is uncertain and is described as "human colorectal and pancreatic carcinoma-associated antigens", a set of tumor antigens isolated from human cancers. The target might be Mucin 5AC. |
Immunogen | n/a |
Other Names | NOE-102, NPC-1C |
Gene, Accession # | n/a |
Catalog # | orb1141090 |
Price | $4317 |
Order / More Info | Ensituximab (biosimilar) Antibody from BIORBYT LTD. |
Product Specific References | n/a |
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558